Literature DB >> 12135955

Medical economics and the assessment of value in cardiovascular medicine: Part I.

Daniel B Mark1, Mark A Hlatky.   

Abstract

Mesh：

Year:  2002        PMID： 12135955     DOI： 10.1161/01.cir.0000021407.93752.7b

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  20 in total

1.  The primacy of clinical effectiveness for cost effectiveness analysis.

Authors:  I P Casserly; E J Topol
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

Review 2.  Cost-effectiveness of myocardial perfusion imaging: a summary of the currently available literature.

Authors:  Roger D Des Prez; Leslee J Shaw; Robert L Gillespie; Wael A Jaber; Gavin L Noble; Prem Soman; David G Wolinsky; Kim A Williams
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

3.  Cost-effectiveness of new tests to diagnose and treat coronary heart disease.

Authors:  Leslee J Shaw; Allen J Taylor; Patrick G O'Malley
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

4.  Percutaneous coronary revascularisation: is it ever worth what it costs?

Authors:  Daniel B Mark
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

Review 5.  Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review.

Authors:  Zaher Fanari; Sandra Weiss; William S Weintraub
Journal:  Am J Cardiovasc Drugs       Date:  2015-12       Impact factor: 3.571

6.  Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.

Authors:  Thomas Rutledge; Tanya S Kenkre; Vera Bittner; David S Krantz; Diane V Thompson; Sarah E Linke; Jo-Ann Eastwood; Wafia Eteiba; Carol E Cornell; Viola Vaccarino; Carl J Pepine; B Delia Johnson; C Noel Bairey Merz
Journal:  Int J Cardiol       Date:  2013-02-12       Impact factor: 4.164

Review 7.  Cost-effectiveness of oral antiplatelet agents--current and future perspectives.

Authors:  Suzanne V Arnold; David J Cohen; Elizabeth A Magnuson
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

8.  Interpreting the results of cost-effectiveness studies.

Authors:  David J Cohen; Matthew R Reynolds
Journal:  J Am Coll Cardiol       Date:  2008-12-16       Impact factor: 24.094

9.  Cost-effectiveness of heart failure therapies.

Authors:  Luis E Rohde; Eduardo G Bertoldi; Livia Goldraich; Carísi A Polanczyk
Journal:  Nat Rev Cardiol       Date:  2013-04-23       Impact factor: 32.419

10.  Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial.

Authors:  Daniel B Mark; J David Knight; Eric J Velazquez; Jonathan G Howlett; John A Spertus; Ljubomir T Djokovic; Tina M Harding; Gena R Rankin; Laura A Drew; Bozena Szygula-Jurkiewicz; Christopher Adlbrecht; Kevin J Anstrom
Journal:  Am Heart J       Date:  2009-04-01       Impact factor: 4.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.